Search
for
Sort by
Research 30 of 316
- Prostate cancer update: 2007
- Prostate cancer update: 2007
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
- Dermatological adverse events with taxane chemotherapy
- Annurca Apple Polyphenols Protect Murine Hair Follicles from Taxane Induced Dystrophy and Hijacks Polyunsaturated Fatty Acid Metabolism toward β-Oxidation
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- THE MULTIFACETED APPROACH TO POLYCYSTIC OVARIAN SYNDROME: A REVIEW OF TRADITIONAL AND ALLOPATHIC MEDICINE
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Hirsutism, Normal Androgens and Diagnosis of PCOS
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- Disruption of microtubules with low intensity ultrasound rescues hair follicle damage by paclitaxel in mouse models
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Malignant epithelial tumors: Part II. Therapy and prevention
- Long-term treatment within a maximum of 96 weeks of tinea unguium with long-pulsed neodymium-doped yttrium aluminum garnet laser
- Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens
- Causes and therapeutic limitations of clinical alopecia and the advent of human pluripotent stem cell follicular transplantation
- Hair and Nail Manifestations of Systemic Disease
- DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice
- Drug safety evaluation of exemestane
- Pathobiology of chemotherapy-induced hair loss
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study